EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Establishment and application of a zebrafish model of Werner syndrome identifies sapanisertib as a potential antiaging drug

Jianlong Ma iD, Yang Chen, Jingmei Song, Qingfeng Ruan, Lianghui Li, Lingfei Luo iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2413719122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jianlong Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering, School of Life Sciences, Liver Cancer Institute of Zhongshan Hospital, Fudan University, Shanghai 200438…. Hauptthemen laut MEDLINE: Werner Syndrome, Aging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is a complex process that affects multiple organs, and the discovery of a pharmacological approach to ameliorate aging is considered the Holy Grail of medicine. Here, we performed an N-ethyl-N-nitrosourea forward genetic screening in zebrafish and identified an accelerated aging mutant named meteor ( met ), harboring a mutation in the Werner syndrome RecQ - like helicase ( wrn ) gene. Loss of wrn leads to a short lifespan and age-related characteristics in the intestine of zebrafish embryos, such as cellular senescence, genomic instability, and epigenetic alteration. Therefore, we conducted a screening of antiaging drugs using the met mutant and revealed that sapanisertib effectively ameliorated most of the aging phenotypes of the mutant. Mechanistically, the geroprotective effects of sapanisertib may be attributed to inhibition of mTORC1/2. Furthermore, sapanisertib also attenuated chronological aging in wild-type aged zebrafish and replicative-senescence in human foreskin fibroblasts. Taken together, our study introduces a unique and efficient model for large-scale antiaging drug screening in vertebrates and suggests sapanisertib as a potential therapeutic option for treating premature aging and promoting healthy aging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Werner SyndromeAgingAnimalsZebrafishDisease Models, AnimalHumansCellular SenescenceFibroblastsWerner Syndrome HelicaseMutationZebrafish Proteins

Stichwörter der Autor:innen

drug screeningmTORC1/2 signalingpremature agingwrn

Substanzen

Werner Syndrome HelicaseZebrafish Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Liver Cancer Institute of Zhongshan Hospital, Fudan University, Shanghai 200438, China.
  • Institute of Developmental Biology and Regenerative Medicine, Southwest University, Chongqing 400715, China.

ORCID-Profile: Jianlong Ma, Lingfei Luo

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)

Zitieren

APA

Ma, J., Chen, Y., Song, J., Ruan, Q., Li, L., & Luo, L. (2025). Establishment and application of a zebrafish model of Werner syndrome identifies sapanisertib as a potential antiaging drug. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2413719122

Vancouver

Ma J, Chen Y, Song J, Ruan Q, Li L, Luo L. Establishment and application of a zebrafish model of Werner syndrome identifies sapanisertib as a potential antiaging drug. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2413719122

BibTeX
@article{Ma2025,
  author = {Ma, Jianlong and Chen, Yang and Song, Jingmei and Ruan, Qingfeng and Li, Lianghui and Luo, Lingfei},
  title = {Establishment and application of a zebrafish model of Werner syndrome identifies sapanisertib as a potential antiaging drug},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2413719122}
}
Kostenlos starten →